Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

Area of Science:

• Infectious Diseases
• Cardiology
• Microbiology

Background:

• Endocarditis is a serious infection affecting heart valves.
• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant challenge in treating bacterial infections.
• Previous studies on bacterial endocarditis in drug addicts often report younger patient demographics.

Purpose of the Study:

• To evaluate cases of endocarditis caused by MRSA in a specific patient population.
• To characterize the demographic and clinical features of MRSA endocarditis in drug addicts.
• To assess the effectiveness of vancomycin treatment for MRSA endocarditis.

Main Methods:

• Retrospective evaluation of 24 endocarditis cases.
• Data collection on patient demographics, acquisition source, and treatment outcomes.
• Analysis of clinical presentation and mortality associated with MRSA endocarditis.

Main Results:

• All 24 cases were community-acquired MRSA endocarditis in drug addicts, aged 21-59 years.
• The patient population was older than typically reported for this condition.
• Vancomycin treatment for 28 days was effective for most patients, with three deaths.

Conclusions:

• MRSA endocarditis can occur in an older drug-addicted population.
• Vancomycin appears to be an adequate therapy for most MRSA endocarditis cases.
• The higher proportion of women may indicate differences in S. aureus carriage.